1. Home
  2. MAIA vs VOC Comparison

MAIA vs VOC Comparison

Compare MAIA & VOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • VOC
  • Stock Information
  • Founded
  • MAIA 2018
  • VOC 2010
  • Country
  • MAIA United States
  • VOC United States
  • Employees
  • MAIA N/A
  • VOC N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • VOC Oil & Gas Production
  • Sector
  • MAIA Health Care
  • VOC Energy
  • Exchange
  • MAIA Nasdaq
  • VOC Nasdaq
  • Market Cap
  • MAIA 56.3M
  • VOC 51.3M
  • IPO Year
  • MAIA 2022
  • VOC 2011
  • Fundamental
  • Price
  • MAIA $1.58
  • VOC $2.71
  • Analyst Decision
  • MAIA
  • VOC
  • Analyst Count
  • MAIA 0
  • VOC 0
  • Target Price
  • MAIA N/A
  • VOC N/A
  • AVG Volume (30 Days)
  • MAIA 398.8K
  • VOC 130.7K
  • Earning Date
  • MAIA 08-11-2025
  • VOC 01-01-0001
  • Dividend Yield
  • MAIA N/A
  • VOC 23.06%
  • EPS Growth
  • MAIA N/A
  • VOC N/A
  • EPS
  • MAIA N/A
  • VOC 0.57
  • Revenue
  • MAIA N/A
  • VOC $11,024,911.00
  • Revenue This Year
  • MAIA N/A
  • VOC N/A
  • Revenue Next Year
  • MAIA N/A
  • VOC N/A
  • P/E Ratio
  • MAIA N/A
  • VOC $4.71
  • Revenue Growth
  • MAIA N/A
  • VOC N/A
  • 52 Week Low
  • MAIA $1.40
  • VOC $2.44
  • 52 Week High
  • MAIA $3.74
  • VOC $5.69
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 45.57
  • VOC 37.14
  • Support Level
  • MAIA $1.50
  • VOC $2.77
  • Resistance Level
  • MAIA $1.73
  • VOC $2.85
  • Average True Range (ATR)
  • MAIA 0.09
  • VOC 0.14
  • MACD
  • MAIA 0.01
  • VOC -0.04
  • Stochastic Oscillator
  • MAIA 42.86
  • VOC 6.10

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About VOC VOC Energy Trust Units of Beneficial Interest

VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.

Share on Social Networks: